Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib with Docetaxel and Gemcitabine for Neoadjuvant Soft Tissue Sarcoma
NCT01719302Phase 2Completed
- Sponsor
- The University of Vermont
- Start
- Oct 2012
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in soft tissue sarcoma (STS), sponsored by The University of Vermont. Started Oct 2012; status: completed.
02
Drugs
pazopanib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT01719302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01719302.